Takeda Launches ORZEYFUL in Japan and China for Narcolepsy Type 1
Takeda says ORZEYFUL (oveporexton) is now available in Japan and China, giving clinicians access to prescribe the treatment for narcolepsy type 1.
Related stories
China Railway Rolling Stock Corp. Q3 Revenue Falls 1.7% YoY
China Railway Rolling Stock Corp. said third-quarter revenue fell 1.7% year over year.
M impact | EQUITY | Oct 30, 2026, 09:13 AM UTC
Corey Fox Launches AEO Services for Shopify Brands
Shopify SEO consultant Corey Fox has launched AEO services for Shopify brands.
M impact | EQUITY | Oct 30, 2026, 09:12 AM UTC
Jakarta Stocks Fall 16.7% in October, Worst Since March 2020
M impact | EQUITY | Oct 30, 2026, 09:05 AM UTC
Erste Bank Polska Reports Third-Quarter Profit in Line With Expectations
Growing mortgage lending and resilient net interest income helped offset Poland’s bank tax hike, the bank said.
M impact | EQUITY | Oct 30, 2026, 09:04 AM UTC
European session market picture: S&P 500 -0.84%, Nasdaq 100 -1.95%; EUR/USD +0.15%, WTI +1.61%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 0.84 percent, Nasdaq futures is down 1.95 percent, Dow futures is up 0.18 percent and Russell futures is
M impact | EQUITY | Oct 30, 2026, 09:01 AM UTC
AMD, Nvidia, Micron and Arm shares fall
AMD fell 6.5%, Nvidia 2.5%, Micron 3.7% and Arm 7.5%.
M impact | EQUITY | Oct 30, 2026, 08:59 AM UTC